Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microglia | 12 | 2023 | 152 | 5.550 |
Why?
|
Antineoplastic Agents, Phytogenic | 9 | 2021 | 107 | 4.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2023 | 781 | 4.200 |
Why?
|
Cell Line, Tumor | 43 | 2024 | 2128 | 3.830 |
Why?
|
Anti-Inflammatory Agents | 10 | 2023 | 137 | 3.590 |
Why?
|
Benzoquinones | 7 | 2022 | 34 | 3.590 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2023 | 325 | 3.530 |
Why?
|
1-Methyl-4-phenylpyridinium | 10 | 2021 | 28 | 3.320 |
Why?
|
Cell Proliferation | 19 | 2023 | 1149 | 3.220 |
Why?
|
Chemokine CCL2 | 7 | 2022 | 82 | 3.070 |
Why?
|
Cell Survival | 33 | 2021 | 818 | 3.000 |
Why?
|
Antineoplastic Agents | 10 | 2022 | 756 | 2.990 |
Why?
|
Plant Extracts | 7 | 2021 | 250 | 2.960 |
Why?
|
NF-kappa B | 6 | 2023 | 306 | 2.790 |
Why?
|
Apoptosis | 19 | 2024 | 1317 | 2.790 |
Why?
|
Hydrolyzable Tannins | 4 | 2021 | 14 | 2.770 |
Why?
|
Flavonoids | 5 | 2022 | 78 | 2.610 |
Why?
|
Lipopolysaccharides | 13 | 2023 | 200 | 2.570 |
Why?
|
Antioxidants | 10 | 2024 | 386 | 2.490 |
Why?
|
Biological Products | 4 | 2023 | 67 | 2.420 |
Why?
|
Neuroprotective Agents | 5 | 2022 | 231 | 2.230 |
Why?
|
Breast Neoplasms | 8 | 2024 | 1426 | 2.170 |
Why?
|
L-Lactate Dehydrogenase | 4 | 2021 | 59 | 2.160 |
Why?
|
Lactic Acid | 7 | 2021 | 87 | 2.130 |
Why?
|
Humans | 71 | 2024 | 34853 | 1.980 |
Why?
|
Cytokines | 8 | 2021 | 569 | 1.960 |
Why?
|
Naphthoquinones | 3 | 2018 | 35 | 1.890 |
Why?
|
Glioma | 6 | 2016 | 76 | 1.860 |
Why?
|
Allyl Compounds | 6 | 2024 | 47 | 1.830 |
Why?
|
Monoamine Oxidase | 5 | 2020 | 31 | 1.700 |
Why?
|
Cytostatic Agents | 2 | 2021 | 6 | 1.660 |
Why?
|
Glycolysis | 8 | 2021 | 66 | 1.640 |
Why?
|
MAP Kinase Signaling System | 4 | 2022 | 162 | 1.610 |
Why?
|
Apigenin | 3 | 2019 | 12 | 1.590 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 203 | 1.570 |
Why?
|
Cell Cycle | 7 | 2021 | 309 | 1.510 |
Why?
|
High-Throughput Screening Assays | 4 | 2021 | 63 | 1.480 |
Why?
|
Gossypol | 2 | 2020 | 5 | 1.470 |
Why?
|
Gene Expression | 4 | 2022 | 639 | 1.380 |
Why?
|
Sulfides | 5 | 2024 | 58 | 1.370 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 600 | 1.360 |
Why?
|
NF-E2-Related Factor 2 | 4 | 2023 | 73 | 1.350 |
Why?
|
Mitochondria | 9 | 2014 | 454 | 1.340 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2020 | 22 | 1.340 |
Why?
|
Hydrogen Peroxide | 8 | 2022 | 181 | 1.310 |
Why?
|
Inflammation Mediators | 2 | 2020 | 120 | 1.290 |
Why?
|
Vitis | 2 | 2019 | 29 | 1.280 |
Why?
|
Hydroxamic Acids | 2 | 2018 | 30 | 1.260 |
Why?
|
Neuroblastoma | 11 | 2012 | 128 | 1.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 82 | 1.240 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2018 | 34 | 1.240 |
Why?
|
Interferon-gamma | 6 | 2018 | 235 | 1.230 |
Why?
|
Signal Transduction | 11 | 2023 | 1802 | 1.220 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 968 | 1.210 |
Why?
|
Xanthophylls | 2 | 2023 | 14 | 1.200 |
Why?
|
Animals | 46 | 2022 | 14307 | 1.190 |
Why?
|
Epigenesis, Genetic | 4 | 2022 | 198 | 1.140 |
Why?
|
Glutathione | 8 | 2022 | 160 | 1.130 |
Why?
|
Glucose | 7 | 2020 | 217 | 1.100 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 984 | 1.090 |
Why?
|
Mice | 23 | 2021 | 5668 | 1.080 |
Why?
|
Reactive Oxygen Species | 5 | 2024 | 416 | 1.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2023 | 245 | 1.030 |
Why?
|
Isoquinolines | 2 | 2022 | 40 | 1.020 |
Why?
|
Neoplasms | 3 | 2022 | 1033 | 1.010 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2020 | 146 | 1.000 |
Why?
|
Cell Line | 11 | 2023 | 1289 | 0.990 |
Why?
|
MicroRNAs | 2 | 2021 | 386 | 0.970 |
Why?
|
Paclitaxel | 2 | 2021 | 48 | 0.960 |
Why?
|
Female | 25 | 2024 | 19873 | 0.950 |
Why?
|
Neurodegenerative Diseases | 2 | 2022 | 119 | 0.940 |
Why?
|
Seaweed | 1 | 2022 | 11 | 0.900 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2020 | 88 | 0.890 |
Why?
|
Breast | 2 | 2021 | 134 | 0.890 |
Why?
|
Hesperidin | 1 | 2022 | 5 | 0.880 |
Why?
|
Citrus | 1 | 2022 | 12 | 0.870 |
Why?
|
Prostatic Neoplasms | 4 | 2020 | 794 | 0.860 |
Why?
|
Inflammation | 5 | 2023 | 577 | 0.860 |
Why?
|
Environment | 2 | 2014 | 130 | 0.840 |
Why?
|
Dioscorea | 1 | 2021 | 2 | 0.840 |
Why?
|
Thiophenes | 1 | 2021 | 31 | 0.830 |
Why?
|
Pyridones | 1 | 2021 | 40 | 0.820 |
Why?
|
Phytotherapy | 1 | 2021 | 62 | 0.810 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2021 | 34 | 0.810 |
Why?
|
Brain Neoplasms | 3 | 2015 | 105 | 0.810 |
Why?
|
I-kappa B Kinase | 2 | 2022 | 40 | 0.810 |
Why?
|
Chemokine CXCL1 | 1 | 2021 | 15 | 0.800 |
Why?
|
Benzamides | 2 | 2021 | 76 | 0.790 |
Why?
|
Iridoids | 1 | 2020 | 5 | 0.790 |
Why?
|
Tetrahydroisoquinolines | 2 | 2021 | 17 | 0.780 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2020 | 5 | 0.780 |
Why?
|
Depsides | 1 | 2020 | 3 | 0.770 |
Why?
|
Cataract | 1 | 2020 | 26 | 0.770 |
Why?
|
Cinnamates | 1 | 2020 | 5 | 0.770 |
Why?
|
Reishi | 1 | 2020 | 6 | 0.760 |
Why?
|
Interleukin-8 | 1 | 2020 | 59 | 0.740 |
Why?
|
Herbicides | 3 | 2010 | 44 | 0.740 |
Why?
|
Rats | 20 | 2019 | 3261 | 0.740 |
Why?
|
Neurons | 5 | 2015 | 1130 | 0.730 |
Why?
|
Chalcones | 1 | 2019 | 13 | 0.720 |
Why?
|
Plants, Medicinal | 2 | 2010 | 54 | 0.710 |
Why?
|
Contraceptive Agents, Male | 1 | 2019 | 3 | 0.710 |
Why?
|
Nitric Oxide | 7 | 2023 | 287 | 0.710 |
Why?
|
Epithelial Cells | 2 | 2024 | 366 | 0.700 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 181 | 0.690 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 23 | 0.660 |
Why?
|
Adenocarcinoma | 1 | 2020 | 239 | 0.640 |
Why?
|
Boswellia | 1 | 2017 | 2 | 0.640 |
Why?
|
Interleukin-1alpha | 2 | 2017 | 17 | 0.640 |
Why?
|
Models, Biological | 4 | 2021 | 642 | 0.630 |
Why?
|
Triterpenes | 1 | 2017 | 12 | 0.630 |
Why?
|
Imidazoles | 1 | 2018 | 124 | 0.630 |
Why?
|
Cell Line, Transformed | 4 | 2020 | 87 | 0.630 |
Why?
|
Melanoma | 1 | 2018 | 91 | 0.610 |
Why?
|
Psoralea | 1 | 2017 | 2 | 0.610 |
Why?
|
Nerve Growth Factor | 2 | 2015 | 25 | 0.600 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 9 | 0.600 |
Why?
|
Nitrogen Dioxide | 1 | 2016 | 10 | 0.600 |
Why?
|
Up-Regulation | 4 | 2022 | 490 | 0.590 |
Why?
|
Seeds | 1 | 2017 | 34 | 0.590 |
Why?
|
Genistein | 1 | 2017 | 41 | 0.590 |
Why?
|
Nitric Oxide Synthase Type II | 6 | 2017 | 91 | 0.580 |
Why?
|
Momordica | 2 | 2019 | 14 | 0.570 |
Why?
|
Oxadiazoles | 1 | 2016 | 14 | 0.570 |
Why?
|
Gene Silencing | 1 | 2017 | 143 | 0.570 |
Why?
|
Sepsis | 1 | 2016 | 76 | 0.550 |
Why?
|
Microtubules | 1 | 2016 | 113 | 0.540 |
Why?
|
RNA, Messenger | 5 | 2022 | 1152 | 0.540 |
Why?
|
Silymarin | 1 | 2015 | 2 | 0.530 |
Why?
|
Astrocytes | 3 | 2021 | 203 | 0.530 |
Why?
|
Genes, p53 | 1 | 2015 | 24 | 0.520 |
Why?
|
Isoenzymes | 3 | 2021 | 149 | 0.520 |
Why?
|
Drug Design | 1 | 2016 | 154 | 0.520 |
Why?
|
Phencyclidine | 2 | 2006 | 17 | 0.520 |
Why?
|
Garlic | 3 | 2024 | 31 | 0.520 |
Why?
|
Neurotoxins | 3 | 2020 | 52 | 0.520 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 391 | 0.510 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 53 | 0.510 |
Why?
|
Neurogenesis | 1 | 2015 | 55 | 0.510 |
Why?
|
Alzheimer Disease | 1 | 2022 | 881 | 0.510 |
Why?
|
Tumor Cells, Cultured | 8 | 2019 | 480 | 0.510 |
Why?
|
Down-Regulation | 3 | 2022 | 420 | 0.510 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2014 | 35 | 0.490 |
Why?
|
Depression | 1 | 2020 | 664 | 0.480 |
Why?
|
Escherichia coli | 1 | 2016 | 436 | 0.480 |
Why?
|
Nitric Oxide Synthase | 2 | 2005 | 103 | 0.470 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 355 | 0.470 |
Why?
|
Dopamine | 6 | 2006 | 232 | 0.460 |
Why?
|
Pyruvic Acid | 2 | 2003 | 16 | 0.460 |
Why?
|
Ecosystem | 1 | 2014 | 119 | 0.460 |
Why?
|
Precancerous Conditions | 2 | 2024 | 81 | 0.450 |
Why?
|
TNF Receptor-Associated Factor 2 | 2 | 2023 | 16 | 0.450 |
Why?
|
Carotenoids | 2 | 2023 | 70 | 0.450 |
Why?
|
Macrophages | 1 | 2016 | 431 | 0.450 |
Why?
|
Oxidative Phosphorylation | 2 | 2010 | 49 | 0.430 |
Why?
|
Ascorbic Acid | 1 | 2012 | 63 | 0.420 |
Why?
|
Carcinoma, Renal Cell | 2 | 2022 | 35 | 0.410 |
Why?
|
Ibuprofen | 2 | 2016 | 33 | 0.400 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 65 | 0.400 |
Why?
|
Parkinson Disease | 2 | 2011 | 167 | 0.400 |
Why?
|
Lysophosphatidylcholines | 3 | 2005 | 19 | 0.400 |
Why?
|
Repressor Proteins | 3 | 2022 | 226 | 0.400 |
Why?
|
Manganese | 2 | 2021 | 59 | 0.390 |
Why?
|
Homeostasis | 1 | 2012 | 172 | 0.380 |
Why?
|
Oxidative Stress | 5 | 2024 | 874 | 0.380 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2017 | 107 | 0.380 |
Why?
|
Kinetics | 5 | 2020 | 650 | 0.380 |
Why?
|
Lung Neoplasms | 1 | 2014 | 336 | 0.380 |
Why?
|
Caspase 3 | 2 | 2023 | 194 | 0.380 |
Why?
|
Cytoprotection | 3 | 2009 | 32 | 0.370 |
Why?
|
Acids | 1 | 2009 | 15 | 0.360 |
Why?
|
Cell Movement | 3 | 2022 | 545 | 0.360 |
Why?
|
Chromatography, High Pressure Liquid | 6 | 2019 | 406 | 0.350 |
Why?
|
PC12 Cells | 6 | 2019 | 84 | 0.350 |
Why?
|
Mercury Poisoning | 1 | 2009 | 5 | 0.350 |
Why?
|
MPTP Poisoning | 2 | 2006 | 10 | 0.340 |
Why?
|
Oxidopamine | 2 | 2005 | 18 | 0.310 |
Why?
|
Molecular Structure | 4 | 2017 | 467 | 0.310 |
Why?
|
Manganese Poisoning | 2 | 2020 | 11 | 0.310 |
Why?
|
Histone Deacetylases | 2 | 2018 | 52 | 0.300 |
Why?
|
Dopamine Agents | 1 | 2007 | 24 | 0.300 |
Why?
|
Structure-Activity Relationship | 2 | 2020 | 376 | 0.300 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2006 | 92 | 0.290 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 4 | 0.290 |
Why?
|
Drugs, Chinese Herbal | 2 | 2020 | 20 | 0.290 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 445 | 0.280 |
Why?
|
Lysine | 2 | 2017 | 104 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 298 | 0.270 |
Why?
|
Phospholipids | 2 | 2005 | 68 | 0.270 |
Why?
|
Cell Differentiation | 2 | 2006 | 562 | 0.270 |
Why?
|
Motor Activity | 4 | 2006 | 393 | 0.270 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 131 | 0.260 |
Why?
|
Adenosine Triphosphate | 3 | 2017 | 180 | 0.260 |
Why?
|
Minority Groups | 2 | 2021 | 537 | 0.260 |
Why?
|
Analysis of Variance | 4 | 2017 | 528 | 0.260 |
Why?
|
Gliosis | 1 | 2004 | 22 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 209 | 0.260 |
Why?
|
Proteomics | 2 | 2019 | 302 | 0.250 |
Why?
|
Smoke | 1 | 2005 | 39 | 0.250 |
Why?
|
Blotting, Western | 4 | 2012 | 834 | 0.250 |
Why?
|
Nerve Degeneration | 1 | 2004 | 101 | 0.250 |
Why?
|
p120 GTPase Activating Protein | 1 | 2023 | 3 | 0.250 |
Why?
|
Ubiquinone | 1 | 2004 | 21 | 0.250 |
Why?
|
Benzo(a)pyrene | 2 | 2024 | 122 | 0.250 |
Why?
|
Mutation | 2 | 2022 | 1023 | 0.250 |
Why?
|
Neuroglia | 1 | 2005 | 117 | 0.240 |
Why?
|
DNA Damage | 3 | 2024 | 341 | 0.240 |
Why?
|
Acetylcarnitine | 1 | 2003 | 8 | 0.240 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2023 | 6 | 0.240 |
Why?
|
Receptors, Dopamine D2 | 2 | 2004 | 68 | 0.230 |
Why?
|
Anticarcinogenic Agents | 1 | 2024 | 65 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 139 | 0.230 |
Why?
|
Protective Agents | 1 | 2003 | 22 | 0.230 |
Why?
|
Hydroxydopamines | 1 | 2003 | 4 | 0.230 |
Why?
|
NAD | 1 | 2003 | 39 | 0.230 |
Why?
|
Gluconeogenesis | 1 | 2003 | 10 | 0.230 |
Why?
|
Models, Molecular | 2 | 2017 | 751 | 0.220 |
Why?
|
Corpus Striatum | 2 | 2004 | 99 | 0.220 |
Why?
|
Benzophenanthridines | 1 | 2022 | 9 | 0.220 |
Why?
|
Chemokines | 1 | 2023 | 89 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 157 | 0.220 |
Why?
|
Oxidation-Reduction | 4 | 2004 | 407 | 0.220 |
Why?
|
Chlorides | 2 | 2013 | 52 | 0.220 |
Why?
|
Phenols | 2 | 2021 | 76 | 0.220 |
Why?
|
Catechin | 1 | 2022 | 30 | 0.210 |
Why?
|
Breast Feeding | 1 | 2023 | 105 | 0.210 |
Why?
|
DNA Polymerase beta | 1 | 2021 | 13 | 0.210 |
Why?
|
Bromodeoxyuridine | 1 | 2021 | 22 | 0.210 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2021 | 25 | 0.210 |
Why?
|
Autophagy | 1 | 2022 | 111 | 0.210 |
Why?
|
Superoxides | 2 | 2016 | 51 | 0.210 |
Why?
|
DNA Repair | 2 | 2024 | 181 | 0.200 |
Why?
|
Vimentin | 1 | 2021 | 32 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 117 | 0.200 |
Why?
|
Nitrites | 2 | 2015 | 38 | 0.200 |
Why?
|
S-Adenosylmethionine | 4 | 2005 | 33 | 0.200 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 115 | 0.200 |
Why?
|
Cadherins | 1 | 2021 | 82 | 0.200 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2016 | 112 | 0.200 |
Why?
|
Cation Transport Proteins | 1 | 2020 | 30 | 0.200 |
Why?
|
Antigens, CD | 1 | 2021 | 116 | 0.190 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2020 | 3 | 0.190 |
Why?
|
Acetylcysteine | 2 | 2013 | 58 | 0.190 |
Why?
|
Osteoprotegerin | 1 | 2020 | 11 | 0.190 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 46 | 0.190 |
Why?
|
Drug Discovery | 1 | 2021 | 77 | 0.190 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 81 | 0.190 |
Why?
|
Catalytic Domain | 1 | 2020 | 97 | 0.180 |
Why?
|
Cyclotides | 1 | 2019 | 4 | 0.180 |
Why?
|
Protein Array Analysis | 2 | 2017 | 26 | 0.180 |
Why?
|
Brain | 3 | 2020 | 1268 | 0.180 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2012 | 342 | 0.180 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 183 | 0.180 |
Why?
|
Nerve Growth Factors | 1 | 2019 | 33 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 229 | 0.180 |
Why?
|
Research | 1 | 2021 | 159 | 0.180 |
Why?
|
Male | 12 | 2022 | 18870 | 0.170 |
Why?
|
Behavioral Research | 1 | 2019 | 37 | 0.170 |
Why?
|
Anaerobiosis | 2 | 2009 | 13 | 0.170 |
Why?
|
In Situ Nick-End Labeling | 3 | 2013 | 126 | 0.170 |
Why?
|
Minority Health | 1 | 2019 | 81 | 0.170 |
Why?
|
Binding, Competitive | 2 | 2017 | 103 | 0.160 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 220 | 0.160 |
Why?
|
Smoking | 1 | 2005 | 903 | 0.160 |
Why?
|
Fruit | 1 | 2019 | 159 | 0.160 |
Why?
|
Quality of Life | 1 | 2022 | 459 | 0.160 |
Why?
|
Cell Respiration | 2 | 2010 | 33 | 0.160 |
Why?
|
Disaster Planning | 1 | 2018 | 51 | 0.160 |
Why?
|
Petroselinum | 1 | 2017 | 4 | 0.160 |
Why?
|
Aerobiosis | 2 | 2009 | 15 | 0.150 |
Why?
|
Disasters | 1 | 2018 | 64 | 0.150 |
Why?
|
Central Nervous System Stimulants | 1 | 2019 | 165 | 0.150 |
Why?
|
Cyclonic Storms | 1 | 2018 | 62 | 0.150 |
Why?
|
Methamphetamine | 1 | 2019 | 155 | 0.150 |
Why?
|
Protein Binding | 4 | 2019 | 913 | 0.150 |
Why?
|
Aging | 1 | 2022 | 639 | 0.150 |
Why?
|
Lipid Peroxides | 1 | 2016 | 16 | 0.150 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 21 | 0.150 |
Why?
|
Membrane Proteins | 1 | 2020 | 486 | 0.150 |
Why?
|
Molecular Conformation | 1 | 2017 | 150 | 0.140 |
Why?
|
Drug Synergism | 2 | 2015 | 171 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 109 | 0.140 |
Why?
|
Tubulin | 1 | 2016 | 80 | 0.140 |
Why?
|
Catalase | 1 | 2016 | 106 | 0.140 |
Why?
|
Neutrophils | 1 | 2016 | 124 | 0.140 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 149 | 0.140 |
Why?
|
Enzyme Activation | 1 | 2017 | 423 | 0.140 |
Why?
|
Hela Cells | 1 | 2017 | 344 | 0.140 |
Why?
|
Manganese Compounds | 2 | 2013 | 12 | 0.140 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 430 | 0.130 |
Why?
|
Dacarbazine | 1 | 2015 | 6 | 0.130 |
Why?
|
Universities | 1 | 2018 | 363 | 0.130 |
Why?
|
Etoposide | 1 | 2015 | 21 | 0.130 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.130 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 90 | 0.130 |
Why?
|
Drug Interactions | 2 | 2006 | 137 | 0.130 |
Why?
|
Biomedical Research | 1 | 2019 | 371 | 0.120 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2014 | 28 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 82 | 0.120 |
Why?
|
Hepatocytes | 1 | 2014 | 74 | 0.120 |
Why?
|
Disulfides | 1 | 2014 | 77 | 0.120 |
Why?
|
Prostate | 1 | 2015 | 136 | 0.120 |
Why?
|
Sulfonamides | 1 | 2014 | 75 | 0.120 |
Why?
|
Oxygen Consumption | 2 | 2004 | 98 | 0.120 |
Why?
|
Behavior, Animal | 2 | 2006 | 304 | 0.120 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 396 | 0.120 |
Why?
|
Methylation | 4 | 2006 | 102 | 0.110 |
Why?
|
Pyrimidines | 1 | 2014 | 112 | 0.110 |
Why?
|
Glutamic Acid | 2 | 2021 | 115 | 0.110 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2013 | 12 | 0.110 |
Why?
|
Proteome | 1 | 2014 | 132 | 0.110 |
Why?
|
Estradiol | 1 | 2014 | 244 | 0.110 |
Why?
|
DNA Fingerprinting | 1 | 2012 | 18 | 0.110 |
Why?
|
Heterochromatin | 1 | 2012 | 12 | 0.110 |
Why?
|
Nucleosomes | 1 | 2012 | 27 | 0.110 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 79 | 0.110 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 100 | 0.100 |
Why?
|
Liliaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
Boraginaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
Apiaceae | 1 | 2010 | 3 | 0.100 |
Why?
|
Cells, Cultured | 1 | 2015 | 1442 | 0.100 |
Why?
|
Middle Aged | 2 | 2022 | 9642 | 0.100 |
Why?
|
Melanins | 1 | 2011 | 32 | 0.100 |
Why?
|
Histones | 1 | 2012 | 177 | 0.100 |
Why?
|
Vitamins | 1 | 2011 | 91 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2010 | 55 | 0.090 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2010 | 71 | 0.090 |
Why?
|
Alcohols | 1 | 2009 | 12 | 0.090 |
Why?
|
Fermentation | 1 | 2009 | 25 | 0.090 |
Why?
|
Ketones | 1 | 2009 | 17 | 0.090 |
Why?
|
Florida | 2 | 2023 | 358 | 0.090 |
Why?
|
Mercuric Chloride | 1 | 2009 | 2 | 0.090 |
Why?
|
Buthionine Sulfoximine | 1 | 2009 | 10 | 0.090 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2009 | 17 | 0.090 |
Why?
|
Prognosis | 2 | 2022 | 707 | 0.090 |
Why?
|
Aldehydes | 1 | 2009 | 65 | 0.090 |
Why?
|
Tritium | 2 | 2006 | 48 | 0.090 |
Why?
|
Dizocilpine Maleate | 2 | 2006 | 45 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 5 | 2005 | 1534 | 0.090 |
Why?
|
Sulfhydryl Compounds | 1 | 2009 | 46 | 0.090 |
Why?
|
Amino Acids | 1 | 2009 | 139 | 0.080 |
Why?
|
DNA Methylation | 1 | 2012 | 301 | 0.080 |
Why?
|
S-Adenosylhomocysteine | 2 | 2005 | 8 | 0.080 |
Why?
|
Pyridinium Compounds | 2 | 2005 | 21 | 0.080 |
Why?
|
Dopamine Antagonists | 2 | 2004 | 39 | 0.080 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2006 | 13 | 0.080 |
Why?
|
Fluorescein | 1 | 2007 | 15 | 0.080 |
Why?
|
Luminescence | 1 | 2007 | 22 | 0.080 |
Why?
|
Cytoplasm | 1 | 2007 | 135 | 0.070 |
Why?
|
Membrane Potentials | 1 | 2007 | 213 | 0.070 |
Why?
|
Transcription Factors | 2 | 2022 | 653 | 0.070 |
Why?
|
Biogenic Amines | 1 | 2006 | 10 | 0.070 |
Why?
|
Paraquat | 1 | 2006 | 20 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 173 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 240 | 0.070 |
Why?
|
Neurites | 1 | 2006 | 35 | 0.070 |
Why?
|
N-Methylaspartate | 1 | 2006 | 55 | 0.070 |
Why?
|
Phosphatidylethanolamines | 1 | 2005 | 22 | 0.070 |
Why?
|
Homocysteine | 1 | 2005 | 18 | 0.070 |
Why?
|
Phosphatidylcholines | 1 | 2005 | 45 | 0.070 |
Why?
|
Sympatholytics | 1 | 2005 | 13 | 0.070 |
Why?
|
Neurotoxicity Syndromes | 1 | 2005 | 32 | 0.070 |
Why?
|
Annexin A5 | 1 | 2004 | 24 | 0.070 |
Why?
|
Propidium | 1 | 2004 | 18 | 0.070 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2004 | 21 | 0.070 |
Why?
|
Tyrosine | 1 | 2005 | 109 | 0.070 |
Why?
|
G2 Phase | 1 | 2004 | 25 | 0.060 |
Why?
|
Oxidants | 1 | 2005 | 43 | 0.060 |
Why?
|
Electron Transport Complex III | 1 | 2004 | 12 | 0.060 |
Why?
|
Receptors, Dopamine | 1 | 2004 | 21 | 0.060 |
Why?
|
Drug Combinations | 1 | 2004 | 89 | 0.060 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2024 | 43 | 0.060 |
Why?
|
Phosphoenolpyruvate | 1 | 2003 | 4 | 0.060 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 88 | 0.060 |
Why?
|
Ataxia | 1 | 2003 | 8 | 0.060 |
Why?
|
Stereotyped Behavior | 1 | 2003 | 20 | 0.060 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2023 | 35 | 0.060 |
Why?
|
Monosaccharides | 1 | 2003 | 9 | 0.060 |
Why?
|
Caspases | 1 | 2023 | 132 | 0.060 |
Why?
|
Methionine | 1 | 2002 | 28 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 197 | 0.050 |
Why?
|
Zinc Fingers | 1 | 2022 | 25 | 0.050 |
Why?
|
Parkinsonian Disorders | 1 | 2002 | 35 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2003 | 323 | 0.050 |
Why?
|
Caco-2 Cells | 1 | 2021 | 48 | 0.050 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 45 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 96 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 338 | 0.050 |
Why?
|
Time Factors | 2 | 2019 | 1681 | 0.050 |
Why?
|
Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2021 | 90 | 0.050 |
Why?
|
Mothers | 1 | 2023 | 164 | 0.050 |
Why?
|
Transferrin | 1 | 2020 | 31 | 0.050 |
Why?
|
DNA | 1 | 2024 | 549 | 0.050 |
Why?
|
Survival Rate | 1 | 2021 | 310 | 0.050 |
Why?
|
alpha-Synuclein | 1 | 2020 | 48 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2020 | 57 | 0.050 |
Why?
|
Calcium Channels | 1 | 2020 | 72 | 0.050 |
Why?
|
Brain Chemistry | 3 | 2005 | 134 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 871 | 0.050 |
Why?
|
Biomimetics | 1 | 2019 | 10 | 0.050 |
Why?
|
Infant | 1 | 2023 | 1014 | 0.050 |
Why?
|
Serine Endopeptidases | 1 | 2019 | 36 | 0.040 |
Why?
|
Genotype | 1 | 2021 | 641 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 484 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2019 | 131 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
New Orleans | 1 | 2018 | 11 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2021 | 550 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2020 | 287 | 0.040 |
Why?
|
Protein Conformation | 1 | 2019 | 350 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 117 | 0.040 |
Why?
|
Research Personnel | 1 | 2019 | 133 | 0.040 |
Why?
|
Pregnancy | 1 | 2003 | 1503 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2019 | 158 | 0.040 |
Why?
|
Computer Simulation | 1 | 2019 | 347 | 0.040 |
Why?
|
Texas | 1 | 2018 | 299 | 0.040 |
Why?
|
Aged | 2 | 2021 | 6448 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 92 | 0.040 |
Why?
|
Child | 1 | 2023 | 2875 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 2333 | 0.030 |
Why?
|
Injections, Intraventricular | 2 | 2005 | 60 | 0.030 |
Why?
|
Adipokines | 1 | 2014 | 24 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2018 | 531 | 0.030 |
Why?
|
Puerto Rico | 1 | 2018 | 1352 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2014 | 140 | 0.030 |
Why?
|
Thymine | 1 | 2013 | 25 | 0.030 |
Why?
|
Comet Assay | 1 | 2013 | 72 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2019 | 583 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 75 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2012 | 46 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2015 | 1056 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2013 | 392 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 4012 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2006 | 1530 | 0.020 |
Why?
|
United States | 1 | 2019 | 3894 | 0.020 |
Why?
|
Homovanillic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
Adult | 1 | 2021 | 11034 | 0.020 |
Why?
|
Catheterization | 1 | 2005 | 23 | 0.020 |
Why?
|
Neostriatum | 1 | 2005 | 25 | 0.020 |
Why?
|
Hypokinesia | 1 | 2005 | 2 | 0.020 |
Why?
|
Quinacrine | 1 | 2005 | 4 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2005 | 41 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2005 | 72 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2005 | 37 | 0.020 |
Why?
|
Adenosine | 1 | 2005 | 54 | 0.020 |
Why?
|
Mazindol | 1 | 2004 | 3 | 0.020 |
Why?
|
Methyltransferases | 1 | 2005 | 56 | 0.020 |
Why?
|
Serotonin | 1 | 2005 | 114 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2004 | 61 | 0.020 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 45 | 0.020 |
Why?
|
Receptors, Dopamine D1 | 1 | 2004 | 35 | 0.020 |
Why?
|
Benzazepines | 1 | 2004 | 29 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2004 | 197 | 0.010 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2004 | 75 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 859 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 44 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2002 | 72 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2002 | 91 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 72 | 0.010 |
Why?
|
Liver | 1 | 2005 | 447 | 0.010 |
Why?
|
Cell Membrane | 1 | 2004 | 360 | 0.010 |
Why?
|
Proteins | 1 | 2002 | 352 | 0.010 |
Why?
|